查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2068758

醫療保健領域虛擬實境市場預測——按組件、技術、設備類型、治療領域、應用、最終用戶和地區分類的全球分析——2034年

Virtual Reality in Healthcare Market Forecasts to 2034 - Global Analysis By Component (Hardware, Software, and Services), Technology, Device Type, Therapeutic Area, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

預計到 2026 年，全球醫療領域虛擬實境 (VR) 市場規模將達到 31 億美元，到 2034 年將達到 157 億美元，預測期內複合年成長率為 22.3%。

虛擬實境（VR）在醫療領域利用身臨其境型電腦生成的3D環境，透過頭戴式顯示器和相關硬體，為整個醫療保健行業的臨床、教育和治療提供服務。醫療訓練計畫利用VR模擬器為外科手術、臨床技能和緊急應變場景提供無風險的練習環境。在治療方面，VR應用用於管理急慢性疼痛、進行焦慮症和恐懼症的暴露療法，以及支持神經系統疾病和整形外科患者的運動復健。

擴大身臨其境型模擬技術在醫學教育和外科訓練的應用。

在醫療保健領域，虛擬實境（VR）模擬正日益被認可為傳統屍體和人體模型訓練方法的絕佳補充，它提供了一個可重複、標準化且可衡量的技能發展環境。手術模擬器使受訓人員能夠在不危及患者的情況下練習複雜的手術操作，透過性能分析量化技能提升，並識別具體的技術困難。隨著微創和機器人輔助手術技術的日益複雜，高保真模擬訓練的價值尤其突出。醫療機構將VR培訓計畫視為住院醫師招募和持續醫學教育的競爭優勢，因此在大學附屬醫院和大規模醫院網路中，VR培訓的需求仍然強勁。

動暈症、硬體相關的不適以及臨床工作人員採用的障礙。

相當一部分使用者在使用虛擬實境（VR）裝置時會因暈動症而出現噁心、頭暈和方向感喪失等症狀，尤其是在使用早期視野狹窄、追蹤延遲明顯的VR頭顯時。在臨床環境中，由於醫護人員對技術相關副作用的接受度較低，他們對VR的採用持謹慎態度。此外， VR頭戴裝置的體積較大，在臨床環境中共用使用會帶來衛生方面的挑戰，進而引發實際的感染控制問題。臨床工作人員已經需要適應多種新的數位工具，如果VR的使用者體驗不佳，或者校準和設定要求進一步增加了他們本已緊張的工作流程所需的時間，他們可能會抵制VR的普及。

用於疼痛管理和心理健康治療的治療性虛擬實境應用

越來越多的臨床證據支持基於虛擬實境（VR）的干預措施可用於治療急性疼痛、慢性疼痛、創傷後壓力症候群（PTSD）和恐懼症，從而拓展了VR治療應用範圍，使其超越了單純的訓練範疇。在醫院燒傷病房和換藥過程中應用的VR疼痛管理解決方案已證實能顯著降低患者的疼痛評分和鎮痛藥用量。全球心理健康危機加劇了對擴充性易於獲取的干預方法的需求，尤其加速了VR在心理健康領域的應用。處方箋VR療法的法規核准流程日趨成熟，正在建立一個商業性框架，這將吸引製藥和數位療法領域的大量投資湧入VR醫療保健領域。

VR療法中設備成本高昂且臨床保險報銷途徑有限。

臨床級VR硬體部署成本高昂，加上大多數醫療市場缺乏針對VR治療性介入的既定報銷代碼，這嚴重阻礙了VR技術的商業性化應用。由於缺乏明確的報銷途徑來回收成本，醫院和診所難以證明投資VR療法的合理性。雖然少數處方箋藥在某些地區可以獲得有限的報銷，但大多數VR醫療應用缺乏支持保險覆蓋決策所需的臨床試驗證據。除非保險公司能夠更廣泛地認可VR療法，否則VR療法的應用很可能仍將集中在資金雄厚的學術機構和專科診所。

新型冠狀病毒（COVID-19）的影響：

新冠疫情初期，由於醫療培訓計畫中斷和共用設備使用受限，虛擬實境（VR）技術在醫學領域的應用受到阻礙，但也凸顯了該技術在遠距培訓和隔離患者護理等方面的價值。在實體模擬中心關閉期間，醫院開始採用VR進行員工訓練。疫情過後，隨著醫學教育計畫的重啟以及人們對VR作為長期住院病患互動工具的興趣日益濃厚，市場得以復甦並加速發展。醫療機構正在調整其VR項目，以擴大其臨床應用範圍。

在預測期內，硬體領域預計將佔據最大的市場佔有率。

預計在預測期內，硬體領域將佔據最大的市場佔有率，因為頭戴式顯示器、運動追蹤系統和觸覺設備是虛擬實境（VR）臨床體驗的基礎平台，至關重要。由於對衛生、耐用性和精確度的要求，醫療VR硬體的價格高於消費級設備。大學醫院和軍事醫療訓練計畫中VR模擬中心的日益普及，正顯著推動硬體採購的持續成長。設備技術的不斷進步，例如更輕的頭戴式顯示器、更廣闊的視野和更強大的無線功能，為硬體更換提供了強勁的支撐。

預計在預測期內，基於雲端的虛擬實境解決方案領域將呈現最高的複合年成長率。

在預測期內，基於雲端的虛擬實境（VR）解決方案預計將呈現最高的成長率。這是因為從雲端伺服器串流VR內容降低了終端用戶設備的處理硬體需求，從而實現了在分散的醫療機構中大規模交付高清臨床培訓內容。雲端交付模式無需在每個培訓地點配備高效能本地運算資源，從而降低了VR專案部署的整體成本。雲端VR培訓庫的軟體即服務（SaaS）定價模式降低了小規模醫療機構的進入門檻，並將目標市場大幅擴大到以往在VR醫療領域投資主導的大規模學術機構之外。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率。這主要得益於北美對醫療資訊科技的高額投資、領先的學術醫療中心對虛擬實境（VR）醫療模擬技術的早期應用，以及蓬勃發展的VR醫療新創企業生態系統，這些企業獲得了大量創業投資資金投資。美國軍方對基於VR的醫療培訓項目的投資已產生了臨床檢驗和採購成果，加速了VR技術在民用醫療領域的應用。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於中國和印度對醫療教育基礎設施的大規模投資，以及虛擬實境（VR）模擬技術融入更新後的臨床培訓標準。在中國，由於政府主導的醫療專業人員培訓方法現代化舉措，中國的醫療模擬產業正在快速發展。在日本，由於外科醫生老化以及在培訓病例數量減少的情況下保持手術技能水平的必要性，VR技術在外科領域的應用正在逐步推進。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性評估）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球醫療保健產業虛擬實境市場：按組件分類

  • 硬體
    • VR頭戴裝置
    • 感應器和攝影機
    • 控制器和手套
    • 觸覺設備
    • 運動追蹤系統
  • 軟體
  • 服務

第6章：全球醫療保健領域的虛擬實境市場：依技術分類

  • 非身臨其境型虛擬實境
  • 半沉浸式虛擬實境
  • 完全身臨其境型虛擬實境
  • 聯合虛擬實境平台
  • 基於雲端的虛擬實境解決方案

第7章：全球醫療保健領域虛擬實境市場：按設備類型分類

  • 頭戴式顯示器（HMD）
  • 手勢追蹤設備
  • 投影機和顯示牆
  • VR模擬器
  • 穿戴式虛擬實境設備

第8章：全球醫療保健領域的虛擬實境市場：按治療領域分類

  • 神經病學
  • 循環系統
  • 整形外科
  • 腫瘤學
  • 兒童
  • 心理健康
  • 物理復健

第9章：全球醫療保健領域虛擬實境市場：按應用分類

  • 醫學訓練和教育
  • 患者治療和療法
  • 復健和物理治療
  • 手術計劃和導航
  • 遠端醫療
  • 健身和健康用途

第10章：全球醫療保健產業虛擬實境市場：按最終用戶分類

  • 醫院和診所
  • 學術和研究機構
  • 製藥和生物技術公司
  • 醫療設備製造商
  • 復健中心
  • 診斷中心
  • 病人及居家照護環境

第11章：全球醫療保健領域虛擬實境市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第12章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章：公司簡介

  • Meta Platforms, Inc.
  • Microsoft Corporation
  • Sony Group Corporation
  • HTC Corporation
  • Siemens Healthineers AG
  • Koninklijke Philips NV
  • GE HealthCare Technologies Inc.
  • Surgical Theater, Inc.
  • Osso VR, Inc.
  • AppliedVR, Inc.
  • MindMaze SA
  • Penumbra, Inc.
  • XRHealth USA Inc.
  • VirtaMed AG
  • EON Reality, Inc.
Product Code: SMRC37053

According to Stratistics MRC, the Global Virtual Reality in Healthcare Market is accounted for $3.1 billion in 2026 and is expected to reach $15.7 billion by 2034, growing at a CAGR of 22.3% during the forecast period. Virtual Reality in Healthcare employs immersive, computer-generated three-dimensional environments delivered through head-mounted displays and complementary hardware to serve clinical, educational, and therapeutic purposes across the healthcare sector. Medical training programs use VR simulators to provide risk-free practice environments for surgical procedures, clinical skills, and emergency response scenarios. Therapeutically, VR applications manage acute and chronic pain, deliver exposure therapy for anxiety and phobia disorders, and support motor rehabilitation for neurological and orthopedic patients.

Market Dynamics:

Driver:

Growing adoption of immersive simulation in medical education and surgical training

Medical institutions are increasingly recognizing VR simulation as a superior complement to traditional cadaveric and mannequin-based training approaches, offering repeatable, standardized, and measurable skill development environments. Surgical simulators allow trainees to practice complex procedures without patient risk, with performance analytics quantifying skill progression and identifying specific technique deficiencies. The growing complexity of minimally invasive and robotic surgical techniques makes high-fidelity simulation training particularly valuable. Healthcare institutions view VR training programs as a competitive differentiator in residency recruitment and continuing medical education, sustaining robust procurement demand across academic medical centers and large hospital networks.

Restraint:

Motion sickness, hardware discomfort, and clinical staff adoption barriers

A meaningful subset of users experience cybersickness nausea, dizziness, and disorientation during VR sessions, particularly in early-generation headsets with limited field of view and tracking latency. Clinical environments have limited tolerance for technology-induced adverse effects, creating cautious adoption among healthcare providers. The physical bulkiness and hygiene challenges of shared VR headsets in clinical settings raise practical infection control concerns. Clinical staff, already adapting to multiple new digital tools, may resist VR integration if the user experience is uncomfortable or if calibration and setup requirements add time to already constrained workflows.

Opportunity:

Therapeutic VR applications for pain management and mental health treatment

Growing clinical evidence supporting VR-based interventions for acute procedural pain, chronic pain conditions, post-traumatic stress disorder, and phobia treatment is expanding the therapeutic application landscape beyond training. VR pain management solutions deployed in hospital burn units and during dressing changes have demonstrated significant reductions in reported pain scores and analgesic requirements. Mental health applications are gaining particular momentum as the global mental health crisis intensifies demand for scalable, accessible intervention modalities. Regulatory clearance pathways for prescription VR therapeutics are maturing, providing commercial frameworks that are attracting substantial pharmaceutical and digital therapeutics investment into the VR healthcare space.

Threat:

High device costs and limited clinical reimbursement pathways for VR therapy

The high acquisition cost of clinical-grade VR hardware, combined with the absence of established reimbursement codes for VR therapeutic interventions in most healthcare markets, creates significant commercial adoption barriers. Hospitals and clinics cannot easily justify VR therapy capital investments without clear reimbursement pathways that enable cost recovery. While a small number of prescription digital therapeutics have achieved limited reimbursement in specific jurisdictions, the majority of VR health applications lack the clinical trial evidence required to support coverage determinations. Without broader payer recognition, VR therapy deployment will remain concentrated in well-funded academic institutions and specialty clinics.

Covid-19 Impact:

The COVID-19 pandemic disrupted VR healthcare adoption in the short term through the suspension of medical training programs and restrictions on shared device usage, but simultaneously highlighted the technology's value for remote training and isolated patient care applications. Hospitals deployed VR for staff training during periods when in-person simulation centers were closed. Post-pandemic, the resumption of medical education programs and growing interest in VR as an engagement tool for long-hospitalized patients has restored and accelerated market momentum, with healthcare organizations rebuilding VR programs with an expanded scope of clinical application.

The Hardware segment is expected to be the largest during the forecast period

The Hardware segment is expected to account for the largest market share during the forecast period, driven by the essential nature of head-mounted displays, motion tracking systems, and haptic devices as the fundamental delivery platform for VR clinical experiences. Healthcare-grade VR hardware commands premium pricing relative to consumer devices due to hygiene, durability, and accuracy requirements. Growing adoption of VR simulation centers in academic medical institutions and military medical training programs generates substantial recurring hardware procurement volumes. Continuous device technology improvements reducing headset weight, expanding field of view, and improving wireless capability are sustaining strong hardware replacement demand.

The Cloud-Based VR Solutions segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Cloud-Based VR Solutions segment is predicted to witness the highest growth rate, as streaming VR content from cloud servers reduces the processing hardware requirements of end-user devices and enables scalable distribution of high-fidelity clinical training content across distributed healthcare organizations. Cloud delivery models reduce the total cost of VR program deployment by eliminating the need for high-performance local computing at each training site. Software-as-a-service pricing models for cloud VR training libraries lower adoption barriers for smaller institutions, substantially broadening the addressable market beyond the large academic centers that have historically dominated VR healthcare investment.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by high healthcare IT investment levels, early adoption of VR medical simulation by leading academic medical centers, and a robust ecosystem of VR healthcare start-ups receiving substantial venture funding. The United States military's investment in VR-based medical training programs has generated clinical validation and procurement experience that has facilitated civilian healthcare adoption.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, propelled by large-scale medical education infrastructure investments across China and India and the integration of VR simulation into updated clinical training standards. China's medical simulation industry is expanding rapidly, supported by government initiatives to modernize healthcare professional training methodology. Japan's aging surgeon population and the need to maintain surgical skill levels with fewer training cases are driving VR adoption in surgical specialty societies.

Key players in the market

Some of the key players in Virtual Reality in Healthcare Market include Meta Platforms, Inc., Microsoft Corporation, Sony Group Corporation, HTC Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Surgical Theater, Inc., Osso VR, Inc., AppliedVR, Inc., MindMaze SA, Penumbra, Inc., XRHealth USA Inc., VirtaMed AG, EON Reality, Inc.

Key Developments:

In April 2026, AppliedVR, Inc. secured expanded commercial contracts with major US hospital systems for its EaseVRx immersive virtual reality chronic pain management program following positive real-world outcomes data demonstrating sustained reductions in opioid analgesic utilization among chronic lower back pain patients completing the multi-session VR therapy protocol.

In February 2026, Meta Platforms, Inc. announced a partnership with a consortium of North American academic medical centers to deploy its Quest 3 enterprise headsets for surgical skills training programs, accompanied by a dedicated healthcare VR content development fund to support the creation of procedure-specific simulation modules across multiple surgical specialties.

Components Covered:

  • Hardware
  • Software
  • Services

Technologies Covered:

  • Non-Immersive VR
  • Semi-Immersive VR
  • Fully Immersive VR
  • Collaborative VR Platforms
  • Cloud-Based VR Solutions

Device Types Covered:

  • Head-Mounted Displays (HMDs)
  • Gesture Tracking Devices
  • Projectors & Display Walls
  • VR Simulators
  • Wearable VR Devices

Therapeutic Areas Covered:

  • Neurology
  • Cardiology
  • Orthopedics
  • Oncology
  • Pediatrics
  • Mental Health
  • Physical Rehabilitation

Applications Covered:

  • Medical Training & Education
  • Patient Treatment & Therapy
  • Rehabilitation & Physical Therapy
  • Surgical Planning & Navigation
  • Remote Healthcare & Telemedicine
  • Fitness & Wellness Applications

End Users Covered:

  • Hospitals & Clinics
  • Academic & Research Institutions
  • Pharmaceutical & Biotechnology Companies
  • Medical Device Companies
  • Rehabilitation Centers
  • Diagnostic Centers
  • Patients & Homecare Settings

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
      • Saudi Arabia
      • United Arab Emirates
      • Qatar
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • Egypt
      • Morocco
      • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Virtual Reality in Healthcare Market, By Component

  • 5.1 Hardware
    • 5.1.1 VR Headsets
    • 5.1.2 Sensors & Cameras
    • 5.1.3 Controllers & Gloves
    • 5.1.4 Haptic Devices
    • 5.1.5 Motion Tracking Systems
  • 5.2 Software
  • 5.3 Services

6 Global Virtual Reality in Healthcare Market, By Technology

  • 6.1 Non-Immersive VR
  • 6.2 Semi-Immersive VR
  • 6.3 Fully Immersive VR
  • 6.4 Collaborative VR Platforms
  • 6.5 Cloud-Based VR Solutions

7 Global Virtual Reality in Healthcare Market, By Device Type

  • 7.1 Head-Mounted Displays (HMDs)
  • 7.2 Gesture Tracking Devices
  • 7.3 Projectors & Display Walls
  • 7.4 VR Simulators
  • 7.5 Wearable VR Devices

8 Global Virtual Reality in Healthcare Market, By Therapeutic Area

  • 8.1 Neurology
  • 8.2 Cardiology
  • 8.3 Orthopedics
  • 8.4 Oncology
  • 8.5 Pediatrics
  • 8.6 Mental Health
  • 8.7 Physical Rehabilitation

9 Global Virtual Reality in Healthcare Market, By Application

  • 9.1 Medical Training & Education
  • 9.2 Patient Treatment & Therapy
  • 9.3 Rehabilitation & Physical Therapy
  • 9.4 Surgical Planning & Navigation
  • 9.5 Remote Healthcare & Telemedicine
  • 9.6 Fitness & Wellness Applications

10 Global Virtual Reality in Healthcare Market, By End User

  • 10.1 Hospitals & Clinics
  • 10.2 Academic & Research Institutions
  • 10.3 Pharmaceutical & Biotechnology Companies
  • 10.4 Medical Device Companies
  • 10.5 Rehabilitation Centers
  • 10.6 Diagnostic Centers
  • 10.7 Patients & Homecare Settings

11 Global Virtual Reality in Healthcare Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 Meta Platforms, Inc.
  • 14.2 Microsoft Corporation
  • 14.3 Sony Group Corporation
  • 14.4 HTC Corporation
  • 14.5 Siemens Healthineers AG
  • 14.6 Koninklijke Philips N.V.
  • 14.7 GE HealthCare Technologies Inc.
  • 14.8 Surgical Theater, Inc.
  • 14.9 Osso VR, Inc.
  • 14.10 AppliedVR, Inc.
  • 14.11 MindMaze SA
  • 14.12 Penumbra, Inc.
  • 14.13 XRHealth USA Inc.
  • 14.14 VirtaMed AG
  • 14.15 EON Reality, Inc.

List of Tables

  • Table 1 Global Virtual Reality in Healthcare Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Virtual Reality in Healthcare Market Outlook, By Component (2023-2034) ($MN)
  • Table 3 Global Virtual Reality in Healthcare Market Outlook, By Hardware (2023-2034) ($MN)
  • Table 4 Global Virtual Reality in Healthcare Market Outlook, By VR Headsets (2023-2034) ($MN)
  • Table 5 Global Virtual Reality in Healthcare Market Outlook, By Sensors & Cameras (2023-2034) ($MN)
  • Table 6 Global Virtual Reality in Healthcare Market Outlook, By Controllers & Gloves (2023-2034) ($MN)
  • Table 7 Global Virtual Reality in Healthcare Market Outlook, By Haptic Devices (2023-2034) ($MN)
  • Table 8 Global Virtual Reality in Healthcare Market Outlook, By Motion Tracking Systems (2023-2034) ($MN)
  • Table 9 Global Virtual Reality in Healthcare Market Outlook, By Software (2023-2034) ($MN)
  • Table 10 Global Virtual Reality in Healthcare Market Outlook, By Services (2023-2034) ($MN)
  • Table 11 Global Virtual Reality in Healthcare Market Outlook, By Technology (2023-2034) ($MN)
  • Table 12 Global Virtual Reality in Healthcare Market Outlook, By Non-Immersive VR (2023-2034) ($MN)
  • Table 13 Global Virtual Reality in Healthcare Market Outlook, By Semi-Immersive VR (2023-2034) ($MN)
  • Table 14 Global Virtual Reality in Healthcare Market Outlook, By Fully Immersive VR (2023-2034) ($MN)
  • Table 15 Global Virtual Reality in Healthcare Market Outlook, By Collaborative VR Platforms (2023-2034) ($MN)
  • Table 16 Global Virtual Reality in Healthcare Market Outlook, By Cloud-Based VR Solutions (2023-2034) ($MN)
  • Table 17 Global Virtual Reality in Healthcare Market Outlook, By Device Type (2023-2034) ($MN)
  • Table 18 Global Virtual Reality in Healthcare Market Outlook, By Head-Mounted Displays (HMDs) (2023-2034) ($MN)
  • Table 19 Global Virtual Reality in Healthcare Market Outlook, By Gesture Tracking Devices (2023-2034) ($MN)
  • Table 20 Global Virtual Reality in Healthcare Market Outlook, By Projectors & Display Walls (2023-2034) ($MN)
  • Table 21 Global Virtual Reality in Healthcare Market Outlook, By VR Simulators (2023-2034) ($MN)
  • Table 22 Global Virtual Reality in Healthcare Market Outlook, By Wearable VR Devices (2023-2034) ($MN)
  • Table 23 Global Virtual Reality in Healthcare Market Outlook, By Therapeutic Area (2023-2034) ($MN)
  • Table 24 Global Virtual Reality in Healthcare Market Outlook, By Neurology (2023-2034) ($MN)
  • Table 25 Global Virtual Reality in Healthcare Market Outlook, By Cardiology (2023-2034) ($MN)
  • Table 26 Global Virtual Reality in Healthcare Market Outlook, By Orthopedics (2023-2034) ($MN)
  • Table 27 Global Virtual Reality in Healthcare Market Outlook, By Oncology (2023-2034) ($MN)
  • Table 28 Global Virtual Reality in Healthcare Market Outlook, By Pediatrics (2023-2034) ($MN)
  • Table 29 Global Virtual Reality in Healthcare Market Outlook, By Mental Health (2023-2034) ($MN)
  • Table 30 Global Virtual Reality in Healthcare Market Outlook, By Physical Rehabilitation (2023-2034) ($MN)
  • Table 31 Global Virtual Reality in Healthcare Market Outlook, By Application (2023-2034) ($MN)
  • Table 32 Global Virtual Reality in Healthcare Market Outlook, By Medical Training & Education (2023-2034) ($MN)
  • Table 33 Global Virtual Reality in Healthcare Market Outlook, By Patient Treatment & Therapy (2023-2034) ($MN)
  • Table 34 Global Virtual Reality in Healthcare Market Outlook, By Rehabilitation & Physical Therapy (2023-2034) ($MN)
  • Table 35 Global Virtual Reality in Healthcare Market Outlook, By Surgical Planning & Navigation (2023-2034) ($MN)
  • Table 36 Global Virtual Reality in Healthcare Market Outlook, By Remote Healthcare & Telemedicine (2023-2034) ($MN)
  • Table 37 Global Virtual Reality in Healthcare Market Outlook, By Fitness & Wellness Applications (2023-2034) ($MN)
  • Table 38 Global Virtual Reality in Healthcare Market Outlook, By End User (2023-2034) ($MN)
  • Table 39 Global Virtual Reality in Healthcare Market Outlook, By Hospitals & Clinics (2023-2034) ($MN)
  • Table 40 Global Virtual Reality in Healthcare Market Outlook, By Academic & Research Institutions (2023-2034) ($MN)
  • Table 41 Global Virtual Reality in Healthcare Market Outlook, By Pharmaceutical & Biotechnology Companies (2023-2034) ($MN)
  • Table 42 Global Virtual Reality in Healthcare Market Outlook, By Medical Device Companies (2023-2034) ($MN)
  • Table 43 Global Virtual Reality in Healthcare Market Outlook, By Rehabilitation Centers (2023-2034) ($MN)
  • Table 44 Global Virtual Reality in Healthcare Market Outlook, By Diagnostic Centers (2023-2034) ($MN)
  • Table 45 Global Virtual Reality in Healthcare Market Outlook, By Patients & Homecare Settings (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.